Literature DB >> 10530601

Evaluation of breast cancer incidence: is the increase due entirely to mammographic screening?

C Harmer1, M Staples, A M Kavanagh.   

Abstract

OBJECTIVES: To examine the trends in the incidence rates of breast cancer in a population with mammographic screening and in the unscreened women within that population.
METHODS: Data consisted of incident cases of breast cancer notified to the Victorian Cancer Registry in Victoria, Australia, between 1988 and 1996 and cases detected in the population-based BreastScreen Program. These data were grouped by age (25-39, 40-49, 50-59, 60-69 and > or = 70 years of age) and size of tumor (< or =10 mm, > 10-< or =15 mm, and > 15 mm). Poisson regression modeling was used to examine trends by age, tumor size, calendar year and availability of screening.
RESULTS: The incidence rate of breast cancer in the total population increased between 1988 and 1996. The greatest increase was seen after 1993 when population-based screening became available. In unscreened women, modeling demonstrated a statistically significant (p < 0.01) 1.5% annual increase in the incidence rate. The annual increase in this rate differed by size of tumor and was approximately 8% (p < 0.01) for small tumors (< or = 10 mm) but not significant for tumors > 10 mm. The greatest increase was in small tumors for women > or = 50 years of age.
CONCLUSION: The incidence of breast cancer has increased since population-based mammographic screening was introduced in 1994. The rate in unscreened women also showed a significant increase. This was greatest in small tumors for women > or = 50 years of age. Whether this will translate into an increase in mortality is uncertain and long-term monitoring is required to determine if cohort and period effects impact on the underlying incidence of breast cancer in Victoria.

Entities:  

Mesh:

Year:  1999        PMID: 10530601     DOI: 10.1023/a:1008949819969

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  6 in total

1.  Breast cancer screening: evidence of benefit depends on the method used.

Authors:  Philippe Autier; Mathieu Boniol
Journal:  BMC Med       Date:  2012-12-12       Impact factor: 8.775

2.  Incidence of breast cancer in Norway and Sweden during introduction of nationwide screening: prospective cohort study.

Authors:  Per-Henrik Zahl; Bjørn Heine Strand; Jan Maehlen
Journal:  BMJ       Date:  2004-03-10

Review 3.  Advanced breast cancer incidence following population-based mammographic screening.

Authors:  P Autier; M Boniol; R Middleton; J F Doré; C Héry; T Zheng; A Gavin
Journal:  Ann Oncol       Date:  2011-01-20       Impact factor: 32.976

4.  Breast cancer incidence and mortality trends in an affluent population: Marin County, California, USA, 1990-1999.

Authors:  Christina A Clarke; Sally L Glaser; Dee W West; Rochelle R Ereman; Christine A Erdmann; Janice M Barlow; Margaret R Wrensch
Journal:  Breast Cancer Res       Date:  2002-07-26       Impact factor: 6.466

5.  Detection and interval cancer rates during the transition from screen-film to digital mammography in population-based screening.

Authors:  Valérie D V Sankatsing; Jacques Fracheboud; Linda de Munck; Mireille J M Broeders; Nicolien T van Ravesteyn; Eveline A M Heijnsdijk; André L M Verbeek; Johannes D M Otten; Ruud M Pijnappel; Sabine Siesling; Harry J de Koning
Journal:  BMC Cancer       Date:  2018-03-05       Impact factor: 4.430

Review 6.  The impact of mammography screening programmes on incidence of advanced breast cancer in Europe: a literature review.

Authors:  M J M Broeders; P Allgood; S W Duffy; S Hofvind; I D Nagtegaal; E Paci; S M Moss; L Bucchi
Journal:  BMC Cancer       Date:  2018-09-03       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.